NanoCellect Biomedical
PrivateLast Round
VC Round
Jun 29, 2023
Total Funding Raised
$50.28M
Company Overview
NanoCellect Biomedical is a biotechnology company that develops microfluidic flow cytometry devices to simplify cell analysis and sorting for biomedical research and drug discovery.
Sector
Healthcare & Life Sciences
Verticals
Biotech Equipment, Biotechnology, Medical Devices, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Hardware Sales, Usage-Based SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NanoCellect Biomedical Comparables
Compare NanoCellect Biomedical with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| On-chip Biotechnologies Co., Ltd. | 86% | |
| Deepcell | 83% | |
| ThinkCyte | 81% | |
NanoCellect Biomedical Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Jun 29, 2023 | ||||
| Grant | Aug 24, 2022 | ||||
| Series D | Aug 1, 2021 | ||||
| Grant | Oct 4, 2019 | ||||
| Series B | Nov 28, 2017 | ||||
Series A | Feb 4, 2016 |
NanoCellect Biomedical Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NIH RADx | Grant |
| Genoa Ventures | Series B |
| FusionX Ventures | Series C, Series B, Series D, Series A |
| Anzu Partners | Series B, Series D |
| Vertical Venture Partners | Series B, Series D, Series C |
| Casdin Capital | Series D |
| Warburg Pincus | Series D |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 1, 2021
$20M round led by Warburg Pincus.
- Sep 1, 2015
$225K grant received from NIH RADx.
NanoCellect Biomedical Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about NanoCellect Biomedical's valuation, stock price, and market status.